Westlake Village skin therapy developer Sienna Biopharmaceuticals plans to raise around $20 million on the public market through a stock offering. The company announced Feb. 20 that it was pricing the 8 million shares at $2.50. Additionally, underwriters will have the option to purchase up to 1.2 million additional shares, potentially bringing the gross proceeds…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
